|
|||||
|
|
Prospective antifungal therapy (PATH) alliance®: focus on mucormycosis |
|
| Authors: | Dimitrios P. Kontoyiannis Nkechi Azie Billy Franks David L. Horn |
| Affiliation: | 1. Department of Infectious Diseases, University of Texas MD Anderson Cancer Center, , Houston, TX, USA;2. Astellas Scientific and Medical Affairs, , Northbrook, IL, USA;3. David Horn LLC, , Doylestown, PA, USA |
| Abstract: | |
| Keywords: | Epidemiology mucormycosis PATH alliance® survival treatment |